Skip to main content
    G

    Gain Therapeutics Inc (GANX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.94
    -0.10 (-9.60%)

    Market Cap: $46.31M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Gain Therapeutics Inc (GANX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Gain Therapeutics are Grace Therapeutics (GRCE), Plus Therapeutics (PSTV) and OS Therapies (OSTX). By market cap, Gain Therapeutics ranks 6th of the 13 companies on this page; Cognition Therapeutics (CGTX) is the largest at $64.65M.

    Peer Comparison

    GANX's ROIC of -170.5% is below the peer median of -51.9%, and its revenue growth of -100.0% is below the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Gain Therapeutics (GANX)$46.31MN/AN/A0.0%-170.5%-100.0%0.00%
    Grace Therapeutics, Inc. (GRCE)$38.08MN/AN/A0.0%N/A0.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    OS Therapies Incorporated (OSTX)$34.87MN/AN/A0.0%218.0%0.0%0.00%
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)$36.15MN/AN/A0.0%N/A0.0%0.00%
    ProMIS Neurosciences Inc. (PMN)$29.60MN/AN/A0.0%N/A0.0%0.00%
    Cognition Therapeutics Inc (CGTX)$64.65MN/AN/A0.0%N/A0.0%0.00%
    Pelthos Therapeutics Inc. (PTHS)$29.24MN/A0.5x-199.5%-95.4%0.0%0.00%
    Heron Therapeuti (HRTX)$59.08MN/A0.4x-14.5%-8.4%-7.8%0.00%
    Rein Therapeutics Inc (RNTX)$47.63MN/AN/A0.0%N/A0.0%0.00%
    Mink Therapeutics Inc (INKT)$47.95MN/A236.3x0.0%N/A0.0%0.00%
    Spero Therapeutics Inc (SPRO)$58.26M11.1x1.3x15.7%N/A-95.6%0.00%
    Pliant Therapeutics Inc (PLRX)$43.21MN/AN/A0.0%N/A-100.0%0.00%
    Peer median$40.64M11.1x1.3x0.0%-51.9%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Gain Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Grace Therapeutics, Inc. (GRCE)
    Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
    GRCE competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    OS Therapies Incorporated (OSTX)
    OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs...
    OSTX competitors
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)
    Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human...
    TELO competitors
    ProMIS Neurosciences Inc. (PMN)
    ProMIS Neurosciences Inc. is a pioneering biotechnology company focused on the development of innovative therapeutic solutions for neurodegenerative diseases...
    PMN competitors
    Cognition Therapeutics Inc (CGTX)
    Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting...
    CGTX competitors
    Pelthos Therapeutics Inc. (PTHS)
    Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
    PTHS competitors
    Heron Therapeuti (HRTX)
    Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs.
    HRTX competitors
    Rein Therapeutics Inc (RNTX)
    Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders...
    RNTX competitors
    Mink Therapeutics Inc (INKT)
    MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic...
    INKT competitors
    Spero Therapeutics Inc (SPRO)
    Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing...
    SPRO competitors
    Pliant Therapeutics Inc (PLRX)
    Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops...
    PLRX competitors

    Frequently Asked Questions About GANX

    Who are Gain Therapeutics' main competitors?

    The companies most similar to Gain Therapeutics include Grace Therapeutics (GRCE), Plus Therapeutics (PSTV), OS Therapies (OSTX), Telomir Pharmaceuticals, Inc. Common Stock (TELO) and ProMIS Neurosciences (PMN), listed from the closest match.

    Who is Gain Therapeutics' biggest competitor?

    Cognition Therapeutics (CGTX) is the largest of the similar companies at $64.65M; Grace Therapeutics (GRCE) is the closest match by business profile, size, sector and industry.

    How does GANX stock compare with its competitors?

    GANX's net margin is 0.0% against a peer median of 0.0%.

    Which of Gain Therapeutics' competitors pays a higher dividend?

    Gain Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Gain Therapeutics bigger than its competitors?

    No. Gain Therapeutics is 6th by market cap among the 13 companies on this page; the largest is Cognition Therapeutics (CGTX) at $64.65M.